Boardroom Alpha
Meeting calendar
ALMU · Annual meeting · Thursday, January 15, 2026

Aeluma Inc

2 nominees · 2 ballot items.

Election of Class I directors DenBaars and Paglia; and approval of Rose, Snyder & Jacobs LLP as independent auditors for 2026, with remuneration to be fixed by the Board.

Market cap
$300M
1Y TSR
+9.9%
Board grade
C
Record date
Nov 21, 2025
Filing
DEF 14A
Meeting concluded · Jan 15, 2026

Follow how the vote landed and what changed on Aeluma Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot2

  1. 1

    Election of Class I Directors

    ManagementBoard: FOR

    Election of Steven P. DenBaars and John Paglia to three-year terms as Class I directors.

  2. 2

    Approval, Ratification, and Confirmation of Re-appointment of Rose, Snyder & Jacobs LLP as the Company’s Independent Auditors for the Year Ending June 30, 2026, and Authorization of Board of Directors to Fix Their Remuneration

    ManagementBoard: FOR

    Approval of the re-appointment of Rose, Snyder & Jacobs LLP as the Company’s independent auditors for the year ending June 30, 2026, and authorization for the Board to fix their remuneration.

Director elections

Nominees on the ballot2

Independent
Tenure on this board
5.1 yrs
Also a director at
Smartkem Inc (SMTK)NONE
Independent
Tenure on this board
4.6 yrs
Also a director at
Simulations Plus Inc (SLP)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC3.2%588,751$8M
2BlackRock, Inc.2.6%469,267$6M
3MILLENNIUM MANAGEMENT LLC2.2%398,299$5M
4BlackRock, Inc.1.7%316,335$4M
5RAYMOND JAMES FINANCIAL INC1.4%254,825$3M
6GEODE CAPITAL MANAGEMENT, LLC1.4%253,636$3M
7STATE STREET CORP1.4%247,345$3M
8APIS CAPITAL ADVISORS, LLC1.1%206,000$3M
9AWM Investment Company, Inc.Activist1.1%200,000$3M
10MARSHALL WACE, LLP0.7%120,932$2M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Aeluma Inc 2026 annual meeting?
Aeluma Inc (ALMU) holds its 2026 annual shareholder meeting on Thursday, January 15, 2026.
What is the record date for the Aeluma Inc 2026 meeting?
The record date for the Aeluma Inc 2026 meeting is Friday, November 21, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Aeluma Inc's 2026 meeting?
The board is presenting 2 director nominees at the Aeluma Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Aeluma Inc 2026 meeting?
Shareholders will vote on 2 proposals at the Aeluma Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer